Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
Cellectar Biosciences reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Cellectar Biosciences reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Cellectar Biosciences received on average a compensation package of $1.5M, a 61% increase compared to previous year.
Average pay of disclosed executives at Cellectar Biosciences
James V. Caruso, Chief Executive Officer, received $2M in total, which increased by 34% compared to 2022. 36% of Caruso's compensation, or $715K, was in option awards. Caruso also received $450K in non-equity incentive plan, $600K in salary, $108K in stock awards, as well as $92K in other compensation.
Jarrod Longcor, Chief Operating Officer, received a compensation package of $1.4M, which increased by 64% compared to previous year. 35% of the compensation package, or $480K, was in salary.
Chad J. Kolean, Chief Financial Officer, earned $1.1M in 2023, a 140% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2024.